Caudal Dexamethasone - Bupivacaine in Neonates

Analgesic Efficacy Of Dexamethasone As Adjuvant To Caudal Bupivacaine For Neonates Undergoing Inguinal Hernia Repair: Randomized Controlled Study

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07609836

Enrollment

150

Registered

2026-05-27

Start date

2026-05-01

Completion date

2026-12-01

Last updated

2026-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

We Are Studying the Effects of Caudal Dexamethasone in Neonates Undergoing Inguinal Hernia Repair

Brief summary

Randomied controlled study Evaluate the effects of caudal Dexamethasone in neonates

Detailed description

Evaluate the additive analgesic effects of caudal Dexamethasone in neonates undergoing inguinal hernia repair. additive side effects if found

Interventions

PROCEDUREWe add Dexamethasone to Bupivacaine as adjuvant to Bupivacaine in neonsates undergoing inguinal hernia repair in Dexamethasone - Bupivacaine group

We add Dexamethasone to Bupivacaine as adjuvant to Bupivacaine in neonates undergoing inguinal hernia repair

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

1 Days to 28 Days

Healthy volunteers

Inclusion criteria

* full term neonate * ASA I \& ASA II * Scheduled for inguinal hernia repair

Exclusion criteria

* Patients with allergies to studied drugs * body weight \<3 kilograms * parents refusal

Design outcomes

Primary

Measure	Time frame	Description
FLACC pain scale (face,leg , activity,cry, consolability) in the first 24 hours postoperative	6 months	Assessment for additive analgesic effects of caudal Dexamethasone

Contacts

CONTACTSawsan Haridy Ahmed Abu El Hassan, Lecturer of anesthesia

sawsan_haridy@med.asu.edu.eg002- 01228118341

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 28, 2026